{"id":607084,"date":"2022-07-07T12:00:01","date_gmt":"2022-07-07T12:00:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=607084"},"modified":"2022-07-07T12:00:01","modified_gmt":"2022-07-07T12:00:01","slug":"nucleotide-market-future-growth-and-future-trend-2030-key-companies-are-promega-corporation-dsm-agilent-technologies-inc","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/nucleotide-market-future-growth-and-future-trend-2030-key-companies-are-promega-corporation-dsm-agilent-technologies-inc_607084.html","title":{"rendered":"Nucleotide Market Future Growth And Future Trend 2030 | Key Companies are Promega Corporation, DSM, Agilent Technologies, Inc"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1657192822.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Nucleotide Market Future Growth And Future Trend 2030 | Key Companies are Promega Corporation, DSM, Agilent Technologies, Inc\" src=\"https:\/\/www.abnewswire.com\/uploads\/1657192822.jpeg\" alt=\"Nucleotide Market Future Growth And Future Trend 2030 | Key Companies are Promega Corporation, DSM, Agilent Technologies, Inc\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Reports and Data| Nucleotide Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Nucleotide Market Regional scope North America; Europe; Asia Pacific<\/div>\n<p style=\"text-align: justify;\">The global&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.reportsanddata.com\/report-detail\/nucleotide-market\">Nucleotide market<\/a>&nbsp;is forecast to reach USD 929.2 Million by 2030, according to a new report by Reports and Data. Due to its extensive usage in the pharmaceutical and food &amp; beverage sectors, the global nucleotide demand is anticipated to see substantial growth over the projected period. Along with pharmaceutical applications, remedial work dominated the property-owned nucleotide market, including improved immunity, beneficial effects on the intestines, and positive effects of stress recovery. Also, increasing R&amp;D around the globe in the domain of dietary nucleotide along with yeast-derived nucleotide for livestock health is anticipated to fuel the growth over the projected timeframe.<\/p>\n<p style=\"text-align: justify;\">The development and extension of nucleotide usage in diagnostic testing to evaluate and check illnesses, including the occurrence of multiple viral infections or a particular form of cancer, is expected to fuel demand in the coming years. However, favorable government policies are projected to drive expanding interest over the forecast period.<\/p>\n<p style=\"text-align: justify;\">The use of nucleotide in nutritional supplements under conditions such as poor diet or stress will help to improve the immune system function that is supposed to propel development. The growing emphasis on human welfare from numerous health and safety organizations is also intended to boost demand over the following years.<\/p>\n<p style=\"text-align: justify;\"><span style=\"text-decoration: underline;\">The COVID-19 impact:<\/span><\/p>\n<p style=\"text-align: justify;\">The global effects of the 2019 coronavirus disease (COVID-19) are now starting to be felt and will have a massive impact on the 2020 Nucleotide market. Production in the organic chemicals market will record a slowdown in growth while demand for some chemicals that have end-use applications in healthcare and food is growing. Moreover, in the first quarter of 2020, following the course unfolded by COVID-19&#8217;s progression to a pandemic, China, a large provider of chemicals to the world, reported a significant decrease in production. This has contributed to an imbalance in the economics of supply-demand, prompting suppliers and consumers alike to renegotiate supply contracts.<\/p>\n<p style=\"text-align: justify;\"><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/e36ce6ff7121ad526b5dcca5bfb784d5.png\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\">To understand how our Nucleotide Market can bring difference to your business strategy:-<a rel=\"nofollow\" href=\"https:\/\/www.reportsanddata.com\/download-summary-form\/3368\">Download Summary<\/a><\/p>\n<p style=\"text-align: justify;\"><span style=\"text-decoration: underline;\">Further key findings from the report suggest<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li>Nucleotide industry&rsquo;s demand for gene chips &amp; microarrays was estimated at more than USD 191.44 million in 2021. The increasing success of this technology among researchers is anticipated to accelerate the market, owing to its potential to run thousands of experiments simultaneously in one research under nearly similar conditions. Also, rising competition in the pharmaceutical industry is expected to test increasing quantities of molecules in smaller amounts among drug candidates. Increase in technological development over the forecast period will also encourage market growth.<\/li>\n<li>In 2019, global demand for nucleotides in pharmaceutics was valued at USD 135.69 million. The thorough use of nucleotide in nutritional supplements under the circumstances such as inadequate nutrition or stress will help improve the immune system activity that is expected to fuel demand development. Additionally, progress is expected to raise the market for nucleotide as active pharmaceutical ingredients (API) in the manufacture of animal drugs.<\/li>\n<li>Asia Pacific is projected to grow at a significant rate among other countries, rising from 2021 to 2030 at a CAGR of 7.0%. The emergence of the region&#8217;s largest producer of nucleotides combined with the demand for nutraceutical and the health food processing industry is supposed to boost demand. However, growing explorations of food &amp; beverage additives, especially in the Asia Pacific, are likely to fuel demand growth in the coming years.<\/li>\n<li>Key participants include Ajinomoto Co., Inc., Star Lake Bioscience Co., Inc., CJ CheilJedang Corporation, Ohly GmbH, Lallemand Inc., ThermoFisher Scientific Inc., NuEra Nutrition,Promega Corporation, Nanjing BioTogether Co., Ltd., and Affymetrix Inc among others.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">For the purpose of this report, Reports and Data has segmented into the Global Nucleotide market based on the product, technology, application, and region:<\/p>\n<p style=\"text-align: justify;\">Product Type Outlook (Revenue, USD Million; 2019-2030)<\/p>\n<ul style=\"text-align: justify;\">\n<li>Food Grade<\/li>\n<li>Lab Grade<\/li>\n<li>Industry Grade<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Technology Outlook (Revenue, USD Million; 2019-2030)<\/p>\n<ul style=\"text-align: justify;\">\n<li>TaqMan Allelic Discrimination<\/li>\n<li>Gene Chips &amp; Microarrays<\/li>\n<li>SNP By Pyrosequencing<\/li>\n<li>Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Application&nbsp;Outlook (Revenue, USD Million; 2019-2030)<\/p>\n<ul style=\"text-align: justify;\">\n<li>Pharmaceuticals<\/li>\n<li>Diagnostics Research<\/li>\n<li>Food &amp; Beverage Additive<\/li>\n<li>Animal Feed Additive<\/li>\n<li>Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Request For Custom Research @&nbsp;&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.reportsanddata.com\/request-customization-form\/3368\" target=\"_blank\">https:\/\/www.reportsanddata.com\/request-customization-form\/3368<\/a><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/reportsanddata.com_38777.html\" rel=\"nofollow\">Reports and Data<\/a><br \/><strong>Contact Person:<\/strong> John Watson<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=nucleotide-market-future-growth-and-future-trend-2030-key-companies-are-promega-corporation-dsm-agilent-technologies-inc\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +1-212-710-1370<br \/><strong>Address:<\/strong>40 Wall St. 28th floor  <br \/><strong>City:<\/strong> New York City<br \/><strong>State:<\/strong> NY 10005<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.reportsanddata.com\/report-detail\/gaming-desktop-market\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.reportsanddata.com\/report-detail\/gaming-desktop-market<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.reportsanddata.com\/report-detail\/gaming-desktop-market\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=nucleotide-market-future-growth-and-future-trend-2030-key-companies-are-promega-corporation-dsm-agilent-technologies-inc\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Reports and Data| Nucleotide Market Nucleotide Market Regional scope North America; Europe; Asia Pacific The global&nbsp;Nucleotide market&nbsp;is forecast to reach USD 929.2 Million by 2030, according to a new report by Reports and Data. Due to its extensive usage in &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/nucleotide-market-future-growth-and-future-trend-2030-key-companies-are-promega-corporation-dsm-agilent-technologies-inc_607084.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-607084","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/607084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=607084"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/607084\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=607084"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=607084"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=607084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}